D-0265-2023 Class III Ongoing
FDA drug recall D-0265-2023 was initiated by Akorn, Inc. on Jan 30, 2023 and is designated Class III. Reason for recall: Failed Stability Specifications: Out of specification test results for viscosity was identified at the 12M stability timepoint. The recall status is ongoing. Affected quantity: 45,117 Bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 15, 2023
- Initiation Date
- Jan 30, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 45,117 Bottles
Product description
Atropine Sulfate Ophthalmic Solution, USP 1%, For Topical Application To The Eye, 2 mL bottle, Sterile, Rx only, Distributed by: Akorn Operating Company LLC, Gurnee, IL 60031. NDC: 17478-215-02
Reason for recall
Failed Stability Specifications: Out of specification test results for viscosity was identified at the 12M stability timepoint.
Distribution pattern
Nationwide in the USA and Puerto Rico
Code information
Lot: 081031A, Exp 2/28/2023
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0265-2023
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026